The Arab Drug Company (EGX:ADCI)

Market Cap	1.93B +133.8%
Revenue (ttm)	1.19B +43.9%
Net Income	222.05M +127.0%
EPS	18.50 +127.8%
Shares Out	12.00M
PE Ratio	8.67
Forward PE	n/a
Dividend	4.17 (2.63%)
Ex-Dividend Date	Oct 28, 2025

Volume	24,500
Average Volume	19,625
Open	158.69
Previous Close	158.69
Day's Range	159.10 - 164.94
52-Week Range	68.50 - 249.98
Beta	0.59
RSI	27.24
Earnings Date	Feb 11, 2026

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 1,148
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ADCI

Financial Performance

In fiscal year 2025, The Arab Drug Company's revenue was 1.12 billion, an increase of 42.35% compared to the previous year's 785.52 million. Earnings were 198.93 million, an increase of 125.18%.